Growth Equity Opportunities Fund IV, LLC

Insider Reports History

Location
Timonium, MD
Signature
/s/ Louis Citron, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Growth Equity Opportunities Fund IV, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
AVEO PHARMACEUTICALS, INC. 10%+ Owner Common Stock 0 $15.00 19 Oct 2022 Direct

Insider Reports Filed by Growth Equity Opportunities Fund IV, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919122054281-growth-equity-opportunities-fund-iv-llc-2022-10-19 AVEO PHARMACEUTICALS, INC. 19 Oct 2022 1 $0 4 10%+ Owner 21 Oct 2022, 16:36